MOUNTAIN VIEW, Calif.,
Feb. 14, 2017 /PRNewswire/ --
Omnicell, Inc., (NASDAQ: OMCL) today announced the introduction of
the Company's leading-edge automated multimed packing solution to
assist pharmacists in improving their patients' medication
adherence. The Omnicell VBM 200F expands Omnicell's medication
adherence product portfolio to include an automated system for
filling and checking its SureMed® by
Omnicell® multimed blister cards. These cards greatly
reduce the complexities of managing and taking multiple
medications. This technology will help enable growth-focused
pharmacies to scale their adherence programs and improve patient
outcomes.
The Omnicell VBM 200F is an automated solution that both
efficiently and accurately fills and checks SureMed multimed
blister cards. By automating many steps of the packing process,
this machine reduces manual labor, cuts operational costs, and
diminishes the possibility of human error. The proven visioning
system has been used successfully in leading packaging equipment
for over 12 years, and helps ensure the accuracy of medications
included in each customized SureMed blister card through size,
shape, and color. This solution is designed to support pharmacists'
efforts to help patients stay true to physician-prescribed
medication regimens and strengthen customer refill loyalty.
Omnicell now has a complete set of solutions supporting the
medication adherence ecosystem. The unparalleled portfolio includes
the market-leading Time My Meds® medication
synchronization software, the proprietary SureMed multimed blister
cards, Guided Packing, and automated packaging solutions including
the VBM 200F and the M5000. Omnicell's announcements today are
supportive of the growing awareness of the benefits of medication
adherence among government agencies. In the United States, 18 states have now passed
laws or implemented regulations to alleviate financial burden to
patients or pharmacies when transitioning to synchronized
medication regimens, and some states have begun providing
reimbursement for multimed packages.
A coordinated program of medication therapy management,
medication synchronization and adherence packaging can help keep
patients healthy and decrease costs associated with medication
nonadherence.1 Each year, the avoidable cost of poor
medication adherence is estimated at more than $105 billion in the U.S. alone.2
With more than 30 million Americans taking five or more
maintenance medications daily, pharmacists need ways to support the
arduous task of keeping patients compliant. According to the World
Health Organization, "although these medications are effective in
combating disease, their full benefits are often not realized
because approximately 50% of patients do not take their medications
as prescribed."
"Omnicell offers our pharmacy partners an innovative suite of
solutions designed to increase patient engagement and improve
medication adherence, which can result in healthier outcomes and
reduced healthcare costs," said Rob
Seim, president, Global Automation and Medication Adherence
at Omnicell. "In addition to the M5000, which remains a crucial
part of our innovation strategy, the Omnicell VBM 200F will enable
pharmacists to grow their business, and it reaffirms our commitment
to offer solutions across the full spectrum of care."
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to
create safer and more efficient ways to manage medications and
supplies across all care settings. As a leader in medication and
supply dispensing automation, central pharmacy automation, IV
robotics, analytics software, and medication adherence and
packaging systems, Omnicell is focused on improving care across the
entire healthcare continuum - from the acute care hospital setting,
to post-acute skilled nursing and long-term care facilities, to the
patient's home.
Over 4,000 customers worldwide use
Omnicell® automation and analytics
solutions to increase operational efficiency, reduce medication
errors, deliver actionable intelligence and improve patient
safety.
Omnicell's innovative medication adherence solutions, used
by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve
patient adherence to prescriptions, helping
to reduce costly hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct
capabilities, particularly in central pharmacy, IV robotics, and
pharmacy software, creating the broadest medication management
product portfolio in the industry.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external website,
omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks
of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
1 Effect of a pharmacy care program on medication
adherence and persistence, blood pressure, and low-density
lipoprotein cholesterol: a randomized controlled trial. Lee JK, et
al, JAMA, December 6 2006 Vol 296,
No. 21.
2 IMS Institute for Healthcare Informatics. Avoidable
costs in U.S. healthcare: the $200
billion opportunity from using medicines more responsibly.
June 2013 Available at:
http://www.imshealth.com/deployedfiles/imshealth/
Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII_Responsible_
Use_Medicines_2013.pdf. Accessed May 7,
2014.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-launches-innovative-medication-adherence-automated-pharmacy-solution-to-increase-pharmacy-efficiency-and-profitability-300406936.html
SOURCE Omnicell, Inc.